Reduced Subunit Analysis of a Therapeutic Monoclonal Antibody

28th Mar 2022

Biologics represent a growing class of pharmaceuticals being developed to target a variety of disease and illness vectors. As well as established monoclonal antibodies, new modalities are emerging such as bispecific antibodies with differing heavy or light chains. Some of these features such as stoichiometry and glycan profiling can be defined as critical quality attributes (CQAs). Use of subunit analysis through reduction or specifc cleavage enzymes like IdeS can be used to simplify the observed spectra to better qualify these attributes.

Click download to read more ‘Reduced Subunit Analysis of a Therapeutic Monoclonal Antibody’.

Download resource

Related Content

Mass Spectrometry

ADCs

ADC Analytical Services

Downloads

Reduced Subunit Analysis of a Cysteine Linked Antibody Drug Conjugate

Downloads

Intact Mass Analysis of a Therapeutic Monoclonal Antibody Biosimilar

Downloads

Native Intact Analysis of a Cysteine Linked Antibody Drug Conjugate

Downloads

Intact Mass Analysis of a Therapeutic Lysine Linked Antibody Drug Conjugate

Downloads

Peptide Digestion Analysis of a Monoclonal Therapeutic Antibody

Downloads

Measurement of ADC Stability in Plasma via Released Payload Quantitation

Downloads

Measurement of ADC Stability in Serum via Subunit DAR Analysis